Inspire Investing LLC Acquires 12,705 Shares of Maximus, Inc. $MMS

Key Points

• Inspire Investing LLC significantly increased its stake in Maximus, Inc. by 251.8%, purchasing an additional 12,705 shares, bringing its total holdings to 17,751 shares valued at approximately $1.25 million.
• Maximus reported strong quarterly earnings, with earnings per share of $2.16, surpassing analyst expectations of $1.39, and a year-over-year revenue increase of 2.5%.
• The company recently announced a quarterly dividend of $0.30, which will be paid on December 1st, representing an annualized yield of 1.4%.

Inspire Investing LLC boosted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 251.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,751 shares of the health services provider's stock after purchasing an additional 12,705 shares during the period. Inspire Investing LLC's holdings in Maximus were worth $1,246,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. LRI Investments LLC lifted its stake in Maximus by 11.9% during the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock worth $125,000 after purchasing an additional 195 shares during the last quarter. Verus Financial Partners Inc. lifted its stake in Maximus by 6.7% during the second quarter. Verus Financial Partners Inc. now owns 3,387 shares of the health services provider's stock worth $244,000 after purchasing an additional 214 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock worth $2,351,000 after purchasing an additional 221 shares during the last quarter. Vestcor Inc lifted its stake in Maximus by 2.3% during the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after purchasing an additional 223 shares during the last quarter. Finally, UMB Bank n.a. lifted its stake in Maximus by 37.5% during the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider's stock worth $58,000 after purchasing an additional 227 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Down 3.2%

Shares of NYSE:MMS opened at $85.43 on Friday. The company has a fifty day moving average of $86.71 and a 200-day moving average of $76.16. The company has a market capitalization of $4.81 billion, a PE ratio of 15.73 and a beta of 0.57. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.73.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.Maximus's quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Friday, November 14th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, November 14th. Maximus's dividend payout ratio is presently 22.10%.

Insiders Place Their Bets

In related news, insider Michelle F. Link sold 1,610 shares of the stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the sale, the insider directly owned 13,508 shares in the company, valued at $1,227,336.88. This represents a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. Weiss Ratings upgraded shares of Maximus from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating and two have given a Buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $90.00.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.